These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 16772930

  • 1. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
    Barnea Y, Carmeli Y, Gur E, Kuzmenko B, Gat A, Neville LF, Eren R, Dagan S, Navon-Venezia S.
    Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930
    [Abstract] [Full Text] [Related]

  • 2. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis.
    Faezi S, Sattari M, Mahdavi M, Roudkenar MH.
    Burns; 2011 Aug; 37(5):865-72. PubMed ID: 21334822
    [Abstract] [Full Text] [Related]

  • 3. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S, Safarloo M, Amirmozafari N, Nikokar I, Siadat SD, Holder IA, Mahdavi M.
    APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
    [Abstract] [Full Text] [Related]

  • 4. Therapy with anti-flagellin A monoclonal antibody limits Pseudomonas aeruginosa invasiveness in a mouse burn wound sepsis model.
    Barnea Y, Carmeli Y, Neville LF, Kahel-Reifer H, Eren R, Dagan S, Navon-Venezia S.
    Burns; 2009 May; 35(3):390-6. PubMed ID: 18951715
    [Abstract] [Full Text] [Related]

  • 5. Antibodies raised against N'-terminal Pseudomonas aeruginosa flagellin prevent mortality in lethal murine models of infection.
    Neville LF, Barnea Y, Hammer-Munz O, Gur E, Kuzmenko B, Kahel-Raifer H, Eren R, Elkeles A, Murthy KG, Szabó C, Salzman AL, Dagan S, Carmeli Y, Navon-Venezia S.
    Int J Mol Med; 2005 Jul; 16(1):165-71. PubMed ID: 15942694
    [Abstract] [Full Text] [Related]

  • 6. Antibodies raised against divalent type b flagellin and pilin provide effective immunotherapy against Pseudomonas aeruginosa infection of mice with burn wounds.
    Saffari M, Behbood S, Irajian G, Khorshidi A, Moniri R, Behrouz B.
    Biologicals; 2017 Jan; 45():20-26. PubMed ID: 27836582
    [Abstract] [Full Text] [Related]

  • 7. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.
    Mousavi M, Behrouz B, Irajian G, Mahdavi M, Korpi F, Motamedifar M.
    Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762
    [Abstract] [Full Text] [Related]

  • 8. The establishment of a Pseudomonas aeruginosa-infected burn-wound sepsis model and the effect of imipenem treatment.
    Barnea Y, Carmeli Y, Kuzmenko B, Gur E, Hammer-Munz O, Navon-Venezia S.
    Ann Plast Surg; 2006 Jun; 56(6):674-9. PubMed ID: 16721084
    [Abstract] [Full Text] [Related]

  • 9. Bivalent flagellin immunotherapy protects mice against Pseudomonas aeruginosa infections in both acute pneumonia and burn wound models.
    Ahmadi H, Behrouz B, Irajian G, Amirmozafari N, Naghavi S.
    Biologicals; 2017 Mar; 46():29-37. PubMed ID: 28065582
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of locally delivered polyclonal immunoglobulin against Pseudomonas aeruginosa infection in a murine burn wound model.
    Felts AG, Giridhar G, Grainger DW, Slunt JB.
    Burns; 1999 Aug; 25(5):415-23. PubMed ID: 10439150
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
    Bakht Azad S, Nikokar I, Faezi S, Rasooly S, Mahdavi M.
    Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242
    [Abstract] [Full Text] [Related]

  • 12. Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model.
    Korpi F, Hashemi FB, Irajian G, Fatemi MJ, Laghaei P, Behrouz B.
    Immunol Lett; 2016 Aug; 176():8-17. PubMed ID: 27210422
    [Abstract] [Full Text] [Related]

  • 13. Anti-flagellin IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound murine models in a non-type-specific mode.
    Ahmadi TS, Mousavi Gargari SL, Talei D.
    Mol Immunol; 2021 Aug; 136():118-127. PubMed ID: 34130152
    [Abstract] [Full Text] [Related]

  • 14. Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model.
    McVay CS, Velásquez M, Fralick JA.
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1934-8. PubMed ID: 17387151
    [Abstract] [Full Text] [Related]

  • 15. Effect of transforming growth factor-beta neutralization on survival and bacterial clearance in a murine model of Pseudomonas aeruginosa burn wound infection.
    Huang Z, Pereira C, Toliver-Kinsky T, Murphey ED, Varma TK, Lin CY, Herndon DN, Sherwood ER.
    J Burn Care Res; 2006 Jun; 27(5):682-7. PubMed ID: 16998401
    [Abstract] [Full Text] [Related]

  • 16. Locally delivered antibodies combined with systemic antibiotics confer synergistic protection against antibiotic-resistant burn wound infection.
    Felts AG, Grainger DW, Slunt JB.
    J Trauma; 2000 Nov; 49(5):873-8. PubMed ID: 11086779
    [Abstract] [Full Text] [Related]

  • 17. [Prevention of gram-negative and gram-positive infections with 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection with intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].
    Collins MS, Hector RF, Roby RE, Edwards AA, Ladehoff DK, Dorsey JH.
    Infection; 1987 Nov; 15 Suppl 2():S51-9. PubMed ID: 3112021
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic efficacy of "nubiotics" against burn wound infection by Pseudomonas aeruginosa.
    Dale RM, Schnell G, Wong JP.
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2918-23. PubMed ID: 15273101
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of purified lactonase and ciprofloxacin in preventing systemic spread of Pseudomonas aeruginosa in murine burn wound model.
    Gupta P, Chhibber S, Harjai K.
    Burns; 2015 Feb; 41(1):153-62. PubMed ID: 25015706
    [Abstract] [Full Text] [Related]

  • 20. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
    Meitert E, Sima F, Savulian C, Petrovici M, Chersulick E, Costache G.
    Arch Roum Pathol Exp Microbiol; 1989 Feb; 48(3):237-51. PubMed ID: 2519634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.